Hyogo Prefectural Harima-Himeji General Medical Center

Himeji 670-8560

1 studies enrolling now · 3 studies all time

What they study most

Alzheimer's Disease, Amyloid, Atherosclerotic Cardiovascular Disease (ASCVD), Cognitive Dysfunction, Elevated Lp(a), Lewy Body Disease, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3) — Running, not enrolling